Your session is about to expire
← Back to Search
Anticipated Discomfort Group for Hysteroscopy Surgery
N/A
Waitlist Available
Led By Jose Carugno, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (post-procedure)
Awards & highlights
Study Summary
This trial is testing whether telling patients what to expect during a medical procedure will make them more comfortable.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 (post-procedure)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (post-procedure)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Pain as measured by Visual Analog Scale (VAS)
Secondary outcome measures
Number of participants in each pain category
Trial Design
2Treatment groups
Experimental Treatment
Group I: Objective Description GroupExperimental Treatment1 Intervention
Participants will be prompted using objective description language during the standard of care hysteroscopy.
Group II: Anticipated Discomfort GroupExperimental Treatment1 Intervention
Participants will be prompted using anticipated discomfort language during the standard of care hysteroscopy.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
897 Previous Clinical Trials
409,190 Total Patients Enrolled
Jose Carugno, MDPrincipal InvestigatorUniversity of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Anticipated Discomfort Group
- Group 2: Objective Description Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the participant ceiling for this clinical trial?
"Correct. According to the findings on clinicaltrials.gov, this research project is currently running and recruiting patients; it was initially listed on September 1st 2022 and has been amended recently on October 4th 2022. 70 volunteers are needed at a single site for participation in the trial."
Answered by AI
Has the enrollment process for this research begun yet?
"Affirmative. Clinicaltrials.gov has information that indicates this clinical trial, which was first publicized on September 1st 2022, is presently recruiting for 70 patients at a single medical site."
Answered by AI
Share this study with friends
Copy Link
Messenger